The Pretreatment Systemic Inflammatory Response is an Important Determinant of Poor Pathologic Response for Patients Undergoing Neoadjuvant Therapy for Rectal Cancer

BACKGROUND: Not all patients respond equally to neoadjuvant chemoradiotherapy (nCRT), with subsequent effects on survival. The systemic inflammatory response has been shown to predict long-term outcomes in colorectal cancer. The current study examined the association between systemic inflammation an...

Descripción completa

Detalles Bibliográficos
Autores principales: Dreyer, Stephan B., Powell, Arfon G. M. T., McSorley, Stephen T., Waterston, Ashita, Going, James J., Edwards, Joanne, McMillan, Donald C., Horgan, Paul G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Colorectal Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374176/
https://www.ncbi.nlm.nih.gov/pubmed/27873100
http://dx.doi.org/10.1245/s10434-016-5684-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374176/
https://www.ncbi.nlm.nih.gov/pubmed/27873100
http://dx.doi.org/10.1245/s10434-016-5684-3

Ejemplares similares